These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 27133574)

  • 1. Interleukin-1 receptor is a target for adjunctive control of diazepam-refractory status epilepticus in mice.
    Xu ZH; Wang Y; Tao AF; Yu J; Wang XY; Zu YY; Zhang SH; Chen Z
    Neuroscience; 2016 Jul; 328():22-9. PubMed ID: 27133574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional Knockout of IL-1R1 in Endothelial Cells Attenuates Seizures and Neurodegeneration via Inhibiting Neuroinflammation Mediated by Nrf2/HO-1/NLRP3 Signaling in Status Epilepticus Model.
    Wu L; Zhu Y; Qin Y; Yuan H; Zhang L; Lu T; Chen Q; Hu A
    Mol Neurobiol; 2024 Jul; 61(7):4289-4303. PubMed ID: 38087170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGB1 Is a Therapeutic Target and Biomarker in Diazepam-Refractory Status Epilepticus with Wide Time Window.
    Zhao J; Zheng Y; Liu K; Chen J; Lai N; Fei F; Shi J; Xu C; Wang S; Nishibori M; Wang Y; Chen Z
    Neurotherapeutics; 2020 Apr; 17(2):710-721. PubMed ID: 31802434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diazepam Monotherapy or Diazepam-Ketamine Dual Therapy at Different Time Points Terminates Seizures and Reduces Mortality in a Status Epilepticus Animal Model.
    Zhou R; Wang Y; Cao X; Li Z; Yu J
    Med Sci Monit; 2021 Dec; 27():e934043. PubMed ID: 34866132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466.
    Fritsch B; Stott JJ; Joelle Donofrio J; Rogawski MA
    Epilepsia; 2010 Jan; 51(1):108-17. PubMed ID: 19682025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diazepam administration after prolonged status epilepticus reduces neurodegeneration in the amygdala but not in the hippocampus during epileptogenesis.
    Qashu F; Figueiredo TH; Aroniadou-Anderjaska V; Apland JP; Braga MF
    Amino Acids; 2010 Jan; 38(1):189-97. PubMed ID: 19127342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal and biochemical changes in female Proechimys guyannensis, an animal model of resistance to pilocarpine-induced status epilepticus.
    Sanabria V; Bittencourt S; Perosa SR; de la Rosa T; da Graça Naffah-Mazzacoratti M; Andersen ML; Tufik S; Cavalheiro EA; Amado D
    Sci Rep; 2020 Dec; 10(1):20982. PubMed ID: 33268798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of Correlation between Resistance to Diazepam and Expression of Inflammatory Markers in The Peripheral Blood of Patients with Status Epilepticus.
    Mahama CN; Louisa M; Octaviana F; Suryandari DA; Budikayanti A; Wibowo H
    Acta Med Acad; 2023 Dec; 52(3):169-181. PubMed ID: 38407083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1β biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice.
    Maroso M; Balosso S; Ravizza T; Iori V; Wright CI; French J; Vezzani A
    Neurotherapeutics; 2011 Apr; 8(2):304-15. PubMed ID: 21431948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligandability Assessment of IL-1β by Integrated Hit Identification Approaches.
    Vulpetti A; Rondeau JM; Bellance MH; Blank J; Boesch R; Boettcher A; Bornancin F; Buhr S; Connor LE; Dumelin CE; Esser O; Hediger M; Hintermann S; Hommel U; Koch E; Lapointe G; Leder L; Lehmann S; Lehr P; Meier P; Muller L; Ostermeier D; Ramage P; Schiebel-Haddad S; Smith AB; Stojanovic A; Velcicky J; Yamamoto R; Hurth K
    J Med Chem; 2024 May; 67(10):8141-8160. PubMed ID: 38728572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redefining the ancestral origins of the interleukin-1 superfamily.
    Rivers-Auty J; Daniels MJD; Colliver I; Robertson DL; Brough D
    Nat Commun; 2018 Mar; 9(1):1156. PubMed ID: 29559685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of astrocyte glutamate transporter-1 (GLT1) and aquaporin-4 (AQP4) expression in a model of epilepsy.
    Hubbard JA; Szu JI; Yonan JM; Binder DK
    Exp Neurol; 2016 Sep; 283(Pt A):85-96. PubMed ID: 27155358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of brain metabolites by gas chromatography-mass spectrometry reveals the risk-benefit concerns of prednisone in MRL/lpr lupus mice.
    Zhou J; Lu F; Li S; Xie M; Lu H; Xie Z; Wu D; Wang S; Wen C; Xu ZH
    Inflammopharmacology; 2020 Apr; 28(2):425-435. PubMed ID: 31786803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited preventive effect of prednisone on neuropsychiatric symptoms in murine systemic lupus erythematosus.
    Lu F; Lu H; Xie M; Li S; Zu Y; Zhou J; Yu J; Wang S; Ruan Y; Wen C; Xu Z
    Inflammopharmacology; 2019 Jun; 27(3):511-520. PubMed ID: 30911862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Entorhinal Principal Neurons Mediate Brain-stimulation Treatments for Epilepsy.
    Xu Z; Wang Y; Chen B; Xu C; Wu X; Wang Y; Zhang S; Hu W; Wang S; Guo Y; Zhang X; Luo J; Duan S; Chen Z
    EBioMedicine; 2016 Dec; 14():148-160. PubMed ID: 27908611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-molecule caspase-1 inhibitor CZL80 terminates refractory status epilepticus via inhibition of glutamatergic transmission.
    Wang F; Wang Y; Zhang QY; Hu KY; Song YJ; Yang L; Fei F; Xu CL; Cui SL; Ruan YP; Wang Y; Chen Z
    Acta Pharmacol Sin; 2024 Jul; 45(7):1381-1392. PubMed ID: 38514863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further advances in epilepsy.
    Fawcett J; Davis S; Manford M
    J Neurol; 2023 Nov; 270(11):5655-5670. PubMed ID: 37458794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An
    Cerovic M; Di Nunzio M; Craparotta I; Vezzani A
    Front Neurol; 2023; 14():1129138. PubMed ID: 37034097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into Drug Resistance in Status Epilepticus: Evidence from Animal Models.
    Wang F; Zhang Q; Wang Y; Chen J; Wang Y
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768361
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.